Tech Company Financing Transactions

Entasis Therapeutics Funding Round

Clarus, Frazier Healthcare Partners and AstraZeneca participated in a $50 million Series B funding round for Entasis Therapeutics. The round closed on 4/5/2016.

Transaction Overview

Company Name
Entasis Therapeutics
Announced On
4/5/2016
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Investors

Clarus (Lead Investor) (Nicholas Galakatos)

Frazier Healthcare Partners (Lead Investor) (James Topper)

AstraZeneca

Eventide Asset Management

Novo Ventures

Proceeds Purpose
The proceeds from this financing will enable us to further advance our portfolio of innovative anti-infective products directed at addressing the global health crisis created by the rise in antibiotic resistance in a fundamentally differentiated way.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
35 Gatehouse Dr.
Waltham, MA 02451
USA
Phone
Undisclosed
Website
www.entasistx.com
Email Address
Not Recorded
Overview
Entasis Therapeutics (Nasdaq: ETTX) is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients.
Profile
Entasis Therapeutics LinkedIn Company Profile
Social Media
Entasis Therapeutics Company Twitter Account
Company News
Entasis Therapeutics News
Facebook
Entasis Therapeutics on Facebook
YouTube
Entasis Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Manos Perros
  Manos Perros LinkedIn Profile  Manos Perros Twitter Account  Manos Perros News  Manos Perros on Facebook
Chief Medical Officer
David Altarac
  David Altarac LinkedIn Profile  David Altarac Twitter Account  David Altarac News  David Altarac on Facebook
Chief Scientific Officer
Ruben Tommasi
  Ruben Tommasi LinkedIn Profile  Ruben Tommasi Twitter Account  Ruben Tommasi News  Ruben Tommasi on Facebook
VP - Bus. Development
Michael Gutch
  Michael Gutch LinkedIn Profile  Michael Gutch Twitter Account  Michael Gutch News  Michael Gutch on Facebook
VP - Bus. Development
Eric Kimble
  Eric Kimble LinkedIn Profile  Eric Kimble Twitter Account  Eric Kimble News  Eric Kimble on Facebook
VP - Bus. Development
John Mueller
  John Mueller LinkedIn Profile  John Mueller Twitter Account  John Mueller News  John Mueller on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/5/2016: Peerbridge Health venture capital transaction
Next: 4/5/2016: Persado venture capital transaction

 

Share this article

 

Where The Data Comes From

We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.